Suppliers / Cayman Pharma Sro

Cayman Pharma Sro

Updated 9 July 2026

Cayman Pharma Sro is an API manufacturer. It holds 7 active US drug master files across a filed portfolio of 7 molecules.

7
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Alprostadil SFDA (Saudi Arabia), US FDA 2
Bimatoprost US FDA 1
Epoprostenol US FDA 1
Latanoprost US FDA 1
Latanoprostene Bunod US FDA 1
Tafluprost US FDA 1
Travoprost US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Cayman Pharma Sro comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability